Clinical Trial Update: Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating liposomal bupivacaine (Exparel) for postoperative pain control after open and laparoscopic abdominal hernia repair has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Hernia

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Pain | Phase 4 | Status: COMPLETED | Results posted: 2025-09-10